TACE联合贝伐珠单抗和信迪利单抗治疗不可切除肝细胞癌患者临床疗效研究*
穆亚, 葛乃建, 刘学, 王向东, 徐伟, 杨业发
Clinical efficacy of bevacizumab and sintilimab combination after TACE in the treatment of patients with unresectable hepatocellular carcinoma
Mu Ya, Ge Naijian, Liu Xue, et al
实用肝脏病杂志
.
2025, (5): 751
-754
.
DOI: 10.3969/j.issn.1672-5069.2025.05.028
